Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanjin Jiechangkang Capsule for Ulcerative Colitis
CTR20131108Phase 2Active
- Sponsor
- Guilin Sanjin Pharmaceutical Co., Ltd.
- Start
- Jan 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sanjin jiechangkang in autoimmune colitis, sponsored by Guilin Sanjin Pharmaceutical Co., Ltd.. Started Jan 2014; status: active.
02
Drugs
sanjin jiechangkang
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on CTR20131108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131108.